Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) is now available.
Zhongzhi Pharmaceutical Holdings Limited has announced a change in its board of directors, effective April 10, 2025. Mr. Zhu Shangheng has been appointed as an independent non-executive director, taking over roles previously held by Mr. Wong Kam Wah, who has resigned. Mr. Zhu brings extensive legal expertise, particularly in pharmaceutical law, which could enhance the company’s governance and risk management capabilities.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and is incorporated in the Cayman Islands.
YTD Price Performance: -9.09%
Average Trading Volume: 296,280
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$762.3M
See more data about 3737 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue